How are Menopause Check and Langlebigkeit related?

The Menopause Check and Longevity (Langlebigkeit) test are related through their focus on biological aging processes. Menopause is a major hormonal transition involving estrogen, progesterone, FSH, and inflammatory markers like IL-6. Chronic low-grade inflammation (inflammaging) is a well-established risk factor for age-related diseases and reduced lifespan. A Menopause Check can identify hormonal imbalances that impact cardiovascular health, bone density, and cognition—all domains covered by longevity tests. However, direct causal evidence linking specific menopause markers to overall lifespan is limited to mechanistic and epidemiological studies; no large RCTs confirm that adjusting these markers extends longevity. Combining both tests may provide a more comprehensive risk profile, but consumers should be aware of limitations: hormone levels fluctuate, and longevity genetic scores (e.g., from SNPs) have small effect sizes. Lifestyle factors (diet, exercise, sleep) remain dominant. Evidence is mixed: strong for the role of inflammation in aging, but weak for direct predictive power of consumer tests. Safety note: do not self-treat hormone imbalances based solely on test results; consult a healthcare provider.